Predicting the evolution of relapse in Wilms tumour using drug sensitivity profiling and liquid biopsies
Fördersumme: € 999.538
Personalized risk assessment for embryonal tumor predisposition
Fördersumme: € 999.003
Simultaneous assessment of muscle perfusion and mitochondrial function in ME/CFS
Fördersumme: € 40.000
ME/CFS Biobank Austria
Dauer: 18 Monate, Fördersumme: € 100.000
City-invading mosquitoes of medical importance: habitat preferences and molecular detection in Vienna
Dauer: 36 Monate, Fördersumme: € 768.933
LymphoidStructureMiner: AI-based exploration of the immunological contexture of lymphoid structures in translational research
Dauer: 24 Monate, Fördersumme: € 480.236